Rare disease specialist Concordia Healthcare Corp. recently announced that it will purchase assets of Covis Pharma’s pharma and injectables units for $1.2 billion in cash. Concordia said that it has entered into a definitive agreement to acquire substantially all of the commercial assets of privately held Covis Pharma S.à.r.l and …